Autolus Therapeutics (AUTL) Shareholder's Equity (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 178.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 178.13 Mn |
| Sep 30, 2025 | 265.45 Mn |
| Jun 30, 2025 | 346.46 Mn |
| Mar 31, 2025 | 371.11 Mn |
| Dec 31, 2024 | 427.33 Mn |
| Sep 30, 2024 | 476.97 Mn |
| Jun 30, 2024 | 527.84 Mn |
| Mar 31, 2024 | 582.03 Mn |
| Dec 31, 2023 | 111.47 Mn |
| Sep 30, 2023 | 180.52 Mn |
| Jun 30, 2023 | 229.34 Mn |
| Mar 31, 2023 | 266.92 Mn |
| Dec 31, 2022 | 298.67 Mn |
| Sep 30, 2022 | 161.15 Mn |
| Jun 30, 2022 | 214.52 Mn |
| Mar 31, 2022 | 271.14 Mn |
| Dec 31, 2021 | 313.32 Mn |
| Sep 30, 2021 | 244.73 Mn |
| Jun 30, 2021 | 283.68 Mn |
| Mar 31, 2021 | 299.57 Mn |
| Dec 31, 2020 | 210.03 Mn |
| Sep 30, 2020 | 236.81 Mn |
| Jun 30, 2020 | 258.95 Mn |
| Mar 31, 2020 | 287.48 Mn |
| Dec 31, 2019 | 254.84 Mn |
| Sep 30, 2019 | 269.64 Mn |
| Jun 30, 2019 | 298.22 Mn |
| Dec 31, 2018 | 232.64 Mn |
| Sep 30, 2018 | 255.47 Mn |
| Dec 31, 2017 | 137.52 Mn |
| Sep 30, 2017 | 142.60 Mn |